16th Nov 2006 15:15
Genus PLC16 November 2006 For Immediate Release 16 November 2006 Genus plc Result of AGM Move from AIM to the Official List Board Appointment Genus plc ("Genus") is pleased to announce that at its Annual General Meeting held today, all resolutions were passed. The resolutions included shareholder approval to the Company's proposed move from AIM to the Official List. It is intended that the move will take place at a time after the announcement in March 2007 of Genus' interim results statement for the six month period ended 31 December 2006 which will be prepared in accordance with IFRS. Genus is also pleased to announce the appointment of Professor Barry Furr, OBE,as a non-executive director with effect from 1st December 2006. Professor Furr, aged 62, recently retired as Chief Scientist and Head of ProjectEvaluation for AstraZeneca plc after 34 years of service. He was awarded an OBEin 2000 for his services to cancer drug discovery and was the inventor ofZoladex, a world leading anti-cancer drug. John Hawkins, Chairman of Genus, said: "Genus currently invests in excess of £12m per annum in research anddevelopment. In addition to his duties on the Board, Professor Furr will chair aGenus R&D Steering Group, comprising leading scientists in biotechnology andanimal genetics from around the world, which has the over-riding objective ofachieving early commercial breakthroughs for Genus. The Board believes ProfessorFurr's substantial knowledge and experience in bioscience will contributesignificantly to the future success of Genus." The following is disclosed in accordance with Schedule 2 of the AIM Rules: Current Directorships Directorships in the last 5 yearsThe Biosciences Federation Biscientifica LtdCancer Research UK AstraZeneca India Private LtdBreast Cancer CampaignManchester Technology Fund LtdAcademy of Medical SciencesAvesthagan Ltd India There are no other matters under paragraph (g) of Schedule 2 of the AIM rules tobe disclosed. For further information please contact: Genus plc Tel: 01256 347 100Richard Wood, Chief ExecutiveDavid Timmins, Finance Director Buchanan Communications Tel: 020 7466 5000Charles RylandSuzanne BrocksSimon Potter This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Genus